Advanced search
Publication Cover
Hematology Volume 28, 2023 - Issue 1
Submit an article Journal homepage
763
Views
0
CrossRef citations to date
0
Altmetric
Case Report

Strong positive light chain immunostaining in a patient with transthyretin amyloidosis

Jiao ChenDepartment of Hematology, Shenzhen Luohu Hospital Group Luohu People's Hospital, Shenzhen, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0001-5249-5437
ORCID Icon,
Haifei ChenDepartment of Hematology, Shenzhen Luohu Hospital Group Luohu People's Hospital, Shenzhen, People’s Republic of ChinaCorrespondence[email protected]
,
Lingyun ZhouDepartment of Hematology, Shenzhen Luohu Hospital Group Luohu People's Hospital, Shenzhen, People’s Republic of China
,
Danbo LiuDepartment of Hematology, Shenzhen Luohu Hospital Group Luohu People's Hospital, Shenzhen, People’s Republic of China
,
Fang DuDepartment of Hematology, Shenzhen Luohu Hospital Group Luohu People's Hospital, Shenzhen, People’s Republic of China
&
Hongxian XiangDepartment of Hematology, Shenzhen Luohu Hospital Group Luohu People's Hospital, Shenzhen, People’s Republic of China
Article: 2244315 | Received 07 May 2023, Accepted 25 Jul 2023, Published online: 08 Aug 2023

References

  • Gertz MA, Dispenzieri A. Systemic amyloidosis recognition, prognosis, and therapy: a systematic review. JAMA. 2020 Jul 7;324(1):79–89. doi:10.1001/jama.2020.5493. PMID: 32633805.
  • Benson MD, Buxbaum JN, Eisenberg DS, et al. Amyloid nomenclature 2020: update and recommendations by the International Society of Amyloidosis (ISA) nomenclature committee. Amyloid. 2020 Dec;27(4):217–222. doi:10.1080/13506129.2020.1835263. Epub 2020 Oct 26. PMID: 33100054.
  • Yakupova EI, Bobyleva LG, Vikhlyantsev IM, et al. Congo Red and amyloids: history and relationship. Biosci Rep. 2019 Jan 15;39(1):BSR20181415. doi:10.1042/BSR20181415. PMID: 30567726.
  • Leung N, Nasr SH, Sethi S. How I treat amyloidosis: the importance of accurate diagnosis and amyloid typing. Blood. 2012 Oct 18;120(16):3206–3213. doi:10.1182/blood-2012-03-413682. Epub 2012 Sep 4. PMID: 22948045.
  • Aoki M, Kang D, Katayama A, et al. Optimal conditions and the advantages of using laser microdissection and liquid chromatography tandem mass spectrometry for diagnosing renal amyloidosis. Clin Exp Nephrol. 2018 Aug;22(4):871–880. doi:10.1007/s10157-018-1533-y. Epub 2018 Jan 25. PMID: 29372474.
  • Rezk T, Gilbertson JA, Mangione PP, et al. The complementary role of histology and proteomics for diagnosis and typing of systemic amyloidosis. J Pathol Clin Res. 2019 Jul;5(3):145–153. doi:10.1002/cjp2.126. Epub 2019 Apr 2. PMID: 30740936.
  • Gertz M, Adams D, Ando Y, et al. Avoiding misdiagnosis: expert consensus recommendations for the suspicion and diagnosis of transthyretin amyloidosis for the general practitioner. BMC Fam Pract. 2020 Sep 23;21(1):198. doi:10.1186/s12875-020-01252-4. PMID: 32967612.
  • Garcia-Pavia P, Rapezzi C, Adler Y, et al. Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur J Heart Fail. 2021 Apr;23(4):512–526. doi:10.1002/ejhf.2140. Epub 2021 Apr 7. PMID: 33826207.
  • Dorbala S, Ando Y, Bokhari S, et al. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 2 of 2-diagnostic criteria and appropriate utilization. Circ Cardiovasc Imaging. 2021 Jul;14(7):e000030. doi:10.1161/HCI.0000000000000030. Epub 2021 Jul 1. PMID: 34196222.
  • Vrana JA, Gamez JD, Madden BJ, et al. Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens. Blood. 2009 Dec 3;114(24):4957–4959. doi:10.1182/blood-2009-07-230722. Epub 2009 Oct 1. PMID: 19797517.
  • Bustamante JG, Zaidi SRH. Amyloidosis. [Updated 2022 Aug 9]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-.
  • Sekijima Y. Transthyretin (ATTR) amyloidosis: clinical spectrum, molecular pathogenesis and disease-modifying treatments. J Neurol Neurosurg Psychiatry. 2015 Sep;86(9):1036–1043. doi:10.1136/jnnp-2014-308724. Epub 2015 Jan 20. PMID: 25604431
  • Chen Z, Koh JS, Saini M, et al. Hereditary transthyretin amyloidosis- clinical and genetic characteristics of a multiracial South-East Asian cohort in Singapore. J Neuromuscul Dis. 2021;8(4):723–733. doi:10.3233/JND-210656. PMID: 34024775.
  • Wang S, Peng W, Pang M, et al. Clinical profile and prognosis of hereditary transthyretin amyloid cardiomyopathy: a single-center study in South China. Front Cardiovasc Med. 2022 Jun 27;9:900313. doi:10.3389/fcvm.2022.900313. PMID: 35833187.
  • Du K, Li F, Wang H, et al. Hereditary transthyretin amyloidosis in mainland China: a unicentric retrospective study. Ann Clin Transl Neurol. 2021 Apr;8(4):831–841. doi:10.1002/acn3.51328. Epub 2021 Mar 19. PMID: 33739616.
  • Palstrøm NB, Rojek AM, Møller HEH, et al. Classification of amyloidosis by model-assisted mass spectrometry-based proteomics. Int J Mol Sci. 2021 Dec 28;23(1):319. doi:10.3390/ijms23010319. PMID: 35008745.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.